Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma

Title
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 27, Issue 1, Pages 276-287
Publisher
American Association for Cancer Research (AACR)
Online
2020-11-25
DOI
10.1158/1078-0432.ccr-20-2291

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search